Clinical use of a growth hormone receptor antagonist in the treatment of acromegaly

By Drake W.M.   Parkinson C.   Besser G.M.   Trainer P.J.  

Trends in Endocrinology and Metabolism, Vol. 12, Iss. 9, 2001-11 ,pp. : 408-413

Elsevier

Access to resources Recommend Favorite

Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly

By Bianchi Antonio   Mazziotti Gherardo   Tilaro Laura   Cimino Vincenzo   Veltri Flora   Gaetani Eleonora   Pecorini Giovanni   Pontecorvi Alfredo   Giustina Andrea   Marinis Laura  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 196-199

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Pituitary Tumors: Pegvisomant

By Paisley Angela N.   Drake William M.  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 111-114

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of Acromegaly: Future

By Donangelo Ines   Melmed Shlomo  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 123-128

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of acromegaly: is there still a place for radiotherapy?

By Jallad Raquel   Musolino Nina   Salgado Luiz   Bronstein Marcello  

Pituitary, Vol. 10, Iss. 1, 2007-03 ,pp. : 53-59

Springer Publishing Company

Access to resources Recommend Favorite